Grifols GIKLY
ADR · ADR · CUSIP 398438200
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNew York, NY
- FilingsSEC EDGAR
2
institutional holders
+0 vs Q1 2023
16.0k
shares reported held*
$102.4kreported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $1.7k (-265 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $6.39.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 2 |
| Q4 2022 | 2 |
| Q1 2023 | 2 |
| Q2 2023 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 0 |
| Q1 2023 | 0 | 0 |
| Q2 2023 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| DSM CAPITAL PARTNERS LLC | Reduced | -265 |
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| YOUSIF CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 13.2k $84.4k | Unchanged |
| DSM CAPITAL PARTNERS LLC 0.00% of their portfolio | 2.8k $18.1k | Reduced -265 |